Form 8-K · Current report
Marsh McLennan 8-K, filed Oct 27, 2026
- Filed
- CIK
- 0000062709
- Accession no.
- 0001193125-26-434167
Summary
Marsh & McLennan Companies issued €600 million of 4.250% senior notes due 2032 and €600 million of 4.625% senior notes due 2036, after entering an underwriting agreement with several banks on October 20, 2026. The notes were registered under an existing shelf registration statement and were issued under a supplemental indenture with The Bank of New York Mellon as trustee, with Davis Polk & Wardwell LLP as counsel on the notes' legality.
Key points
- The underwriters — represented by Merrill Lynch International, Deutsche Bank AG London Branch, Barclays Bank PLC and HSBC Bank plc — agreed to purchase the notes from the company.
- The notes were issued October 27, 2026 under a twenty-second supplemental indenture to the company's 2011 indenture with The Bank of New York Mellon as trustee.
- Marsh McLennan also entered a paying agency agreement dated October 27, 2026 with The Bank of New York Mellon, London Branch, as paying agent.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events On October 20, 2026, Marsh & McLennan Companies, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the several underwriters party thereto (the “Underwriters”), pursuant to which the Underwriters agreed to purchase from the Company €600 million aggregate principal amount of its 4.250% Senior Notes due 2032 and €600 million aggregate principal amount of its 4.625% Senior Notes due 2036 (collectively, the “Notes”). The Notes were registered under the Company’s effective shelf registration statement on Form S-3 (Registration No. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.